Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miranda Athanasiou-Metaxa is active.

Publication


Featured researches published by Miranda Athanasiou-Metaxa.


Acta Haematologica | 2007

The Effect of Dietary Habits and Socioeconomic Status on the Prevalence of Iron Deficiency in Children of Northern Greece

Nikolaos Gompakis; Marina Economou; Chaido Tsantali; Vassilios Kouloulias; Maria Keramida; Miranda Athanasiou-Metaxa

Backround: Despite encouraging reports concerning the declining prevalence of iron deficiency, this easily preventable disorder is still an existing problem in presumably developed regions. Objective: To evaluate the prevalence of iron deficiency and relevant anemia in children residing in Northern Greece and to study possible associations. Design: 3,100 children aged 8 months to 15 years were evaluated. Socioeconomic status was determined based on the parents’ profession and place of residence. Nutrition habits were also evaluated. Results: The incidence of iron deficiency was found to be 14% and that of iron deficiency anemia was 2.9%, with a higher prevalence in children younger than 2 years of age. The place of residence was the most significant factor in relation to the development of iron depletion in the children studied. Additional independent factors were revealed to be breast-feeding, meat-containing meal consumption and the consumption of non-home-cooked meals. Conclusion: Iron deficiency remains prevalent in Northern Greece, mainly affecting the vulnerable toddler group. Nutritional iron deficiency is still a severe public health problem even in what are considered to be developed regions. An improvement of dietary habits and an upgrading of semiurban areas should contribute substantially to decreasing the prevalence of iron depletion in Greek children.


Journal of Pediatric Hematology Oncology | 2011

Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.

Andromachi Papagianni; Marina Economou; Athanasios Tragiannidis; Eliza Karatza; Nikolaos Gombakis; Fani Athanassiadou-Piperopoulou; Miranda Athanasiou-Metaxa

Background We conducted a study to evaluate the efficacy of intravenous (IV) anti-D against IV immunoglobulin (IVIG) in newly diagnosed immune thrombocytopenia (ITP) in children and to identify the clinical characteristics of the children most likely to benefit from one or the other treatment. Procedure Children (6 mo to 14 y) with newly diagnosed ITP and a platelet count <20,000/&mgr;L were treated either with a single bolus dose of 50 &mgr;g/kg IV anti-D or with 0.8 to 1 g/kg IVIG in a randomized manner. Results Twenty-five patients, mean age of 6.8 years, were treated either with IV anti-D (n=10) or with IVIG (n=15). Both drugs were equally efficient in raising the platelet count above 20,000/&mgr;L at 24 hours posttreatment. Children who presented with bleeding stage 1 or 2 (no mucosal bleeding) responded better to IVIG treatment, in terms of an increase in platelet count at 24 hours posttreatment (P=0.04). Hemoglobin drop was greater in the anti-D group (P=0.002). Conclusions A single bolus dose of 50 &mgr;g/kg of IV anti-D is a safe and effective first-line treatment in newly diagnosed ITP in childhood and mucosal bleeding is a poor prognostic factor for treatment with IVIG.


European Journal of Pediatrics | 2010

A patient with Lemierre syndrome

Efthimia Vargiami; Evangelia Farmaki; D. Tasiopoulou; Dimitrios I. Zafeiriou; M. Badouraki; A. Anastasiou; Christos D. Karkos; Nikos Gombakis; Miranda Athanasiou-Metaxa

Lemierre syndrome, also known as postanginal sepsis, is a severe complication of an acute oropharyngeal infection that results in septic thrombophlebitis of the ipsilateral internal jugular vein with subsequent septicemia, often complicated by metastatic infections (Syed et al., Laryngoscope 117:1605–1610, 2007). We present the case of a previously healthy 12-year-old boy with Lemierre syndrome, caused by streptococci (Abiotrophia defectiva), complicating a subcutaneous neck abscess. The patient had metastatic sequelae, was treated with antibiotics (clindamycin and vancomycin) and low molecular weight heparin, and had an uneventful outcome.


European Journal of Pediatrics | 2001

Intra-abdominal hemorrhage due to a ruptured corpus luteum cyst in a girl with congenital afibrinogenemia.

Afroditi Koussi; Marina Economou; Miranda Athanasiou-Metaxa


Blood Cells Molecules and Diseases | 2004

Rare thalassemic syndrome caused by interaction of Hb Questembert (α1 codon 131, TCT>CCT, Ser>Pro) with an α-thalassemia-2 deletion: implications for diagnosis and management

Alexandra Stamoulakatou; Miranda Athanasiou-Metaxa; Joanne Traeger-Synodinos; Christina Lazaropoulou; Kees L. Harteveld; Evangelos Premetis; Haido Tsantali; Amine Zorai; Piero C. Giordano; Ioannis Papassotiriou; Emmanuel Kanavakis


Pediatric Neurology | 2008

Hemolytic Anemia Presenting With Idiopathic Intracranial Hypertension

Euthymia Vargiami; Dimitrios I. Zafeiriou; Nikos Gombakis; Fenella J. Kirkham; Miranda Athanasiou-Metaxa


Journal of Pediatric Hematology Oncology | 2002

Co-inheritance of hemoglobin D-punjab and hemoglobin S: case report.

Miranda Athanasiou-Metaxa; Marina Economou; Polixeni Pratsidou; Chaido Tsantali


Blood | 2008

Transient Elastography May Predict Liver Iron Overload in Adult Thalassaemia Patients

Vasilios Perifanis; Efthimia Vlachaki; Emmanouil Sinakos; Raptopoulou-Gigi M; Miranda Athanasiou-Metaxa


Blood | 2011

Deferasirox Safety Profile in Patients with Transfusion-Dependent Anaemias:Results From the Interim Analysis of a Hellenic Study,

Vassilis Ladis; Marouso Drossou; Dimitria Vini; Ersi Voskaridou; Miranda Athanasiou-Metaxa; Marina Oikonomou; Efthimia Vlachaki; Anna Tigka; Christos Tzavelas; Theodora Liakopoulou; Eleni Vrettou; Ioannis Adamopoulos; Antonis Kattamis


Blood | 2009

Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade (R)) in beta-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies

John B. Porter; Miranda Athanasiou-Metaxa; Donald K. Bowden; Jacques Troncy; Dany Habr; Gabor Domokos; Bernard Roubert; Diana Rofail; Adam Gater; Jean-Francois Baladi; M. Domenica Cappellini

Collaboration


Dive into the Miranda Athanasiou-Metaxa's collaboration.

Top Co-Authors

Avatar

Marina Economou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Nikos Gombakis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Dimitrios I. Zafeiriou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Chaido Tsantali

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Euthymia Vargiami

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Nikolaos Gompakis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Efthimia Vlachaki

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge